...
| Panel | ||||||
|---|---|---|---|---|---|---|
| ||||||
JSON File: ct_service_enrolment.json |
Questions | Concepts | ||
|---|---|---|---|
What do you want to do? 🔘 Enrol a new client 🔘 Transfer in a client 🔘 Enrol a Mother into PMTCT program 🔘 Re-enrol a client | |||
Enrolment Date ␣␣-␣␣-␣␣␣␣ 📆 | |||
Unique ID __________________________________ | |||
Other Unique ID __________________________________ | |||
Entry Point 🔽 Voluntary male circumcision clinic 🔽 Private home-based care 🔽 Adolescent outreach program 🔽 Private Company 🔽 Outreach program 🔽 Community-based organization 🔽 Outpatient department 🔽 Pediatric inpatient service 🔽 Voluntary counseling and testing program 🔽 Maternal and child health program 🔽 Vaccination service 🔽 Nutrition program 🔽 Sex worker outreach program 🔽 Intravenous venous drug user outreach program 🔽 Sexually transmitted infection program/clinic 🔽 Under five clinic 🔽 Tuberculosis treatment program 🔽 Adult inpatient service | |||
Entry Point - Other __________________________________ | |||
Population Category 🔘 General population 🔘 Key population 🔘 Priority population | |||
Key Population Type 🔘 Intravenous drug user 🔘 Male who has sex with men 🔘 Prisoners 🔘 Sex worker 🔘 Transgender Persons | |||
Priority Population Type 🔽 Adolescent Girls & Young Women 🔽 Client of sex worker 🔽 Fisher Folk 🔽 Long-distance truck driver 🔽 Migrant Workers 🔽 Non-intravenous drug user 🔽 Refugee 🔽 Uniformed Forces | |||
Transfer-In | |||
Transferring Facility __________________________________ | |||
Start ART Date ␣␣-␣␣-␣␣␣␣ 📆 | |||
Current ART Regimen* (Custom C) 🔽 d4T ABC + 3TC + NVPDTG | HIV_Transfer_In_RegimenPatients Regimen | NVP | 164432 ARV regimen/code for drugs collected
|
Date of Enrolment into HIV Care ␣␣-␣␣-␣␣␣␣ 📆 | |||
HIV Diagnosis | |||
Date Confirmed HIV Positive ␣␣-␣␣-␣␣␣␣ 📆 | |||
Test Type 🔘 Rapid test for HIV 🔘 HIV DNA polymerase chain reaction 🔘 Unknown | |||
Previous ARV/HAART Use | |||
Indication/intent of therapy ☑️ Pre Exposure Prophylaxis (PrEP) ☑️ Prevention of Mother to Child Transmission (PMTCT) ☑️ Post-exposure prophylaxis (PEP) | |||
Use of Pre Exposure Prophylaxis (PrEP) | |||
Use of Post-exposure prophylaxis (PEP)***CC | 164845 Eligible for post-exposure prophylaxis | ||
ART Use for Prevention of Mother to Child Transmission of HIV***CC | 163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program | ||
Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC | NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS) ARVs | ||
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC | NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs | ||
Protease Inhibitors (PIS)***CC | ProteaseInhibitorsProtease Inhibitors (PIS) ARVs | ||
Other HIV Drug Classes | 1193 Current drugs used | ||
Treatment Supporter | |||
Treatment Supporter Name __________________________________ | |||
Treatment Supporter Phone Number __________________________________ | |||
Treatment Supporter Relationship 🔽 Sibling 🔽 Parent 🔽 Partner or spouse 🔽 Guardian 🔽 Grandparent 🔽 Other | |||
Re-enrollment | |||
Date of Re-enrollment ␣␣-␣␣-␣␣␣␣ 📆 | |||
Reason For Re-enrolment __________________________________ | |||